Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer’s disease in the United States and Colombia. The company’s lead product is IGC-AD1 that is in Phase II clinical tri... IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer’s disease in the United States and Colombia. The company’s lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer’s. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer’s disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.006 | -2.08986415883 | 0.2871 | 0.3144 | 0.2802 | 640627 | 0.29602908 | CS |
| 4 | -0.0339 | -10.7619047619 | 0.315 | 0.3197 | 0.2742 | 692909 | 0.29127751 | CS |
| 12 | -0.0134 | -4.55008488964 | 0.2945 | 0.3567 | 0.25 | 1224715 | 0.31251808 | CS |
| 26 | -0.0272 | -8.82257541356 | 0.3083 | 0.36 | 0.242 | 870412 | 0.30805389 | CS |
| 52 | -0.045 | -13.7994480221 | 0.3261 | 0.4985 | 0.242 | 1331707 | 0.36707736 | CS |
| 156 | -0.0261 | -8.49609375 | 0.3072 | 0.9099 | 0.242 | 697105 | 0.37867765 | CS |
| 260 | -1.1289 | -80.0638297872 | 1.41 | 4.65 | 0.242 | 968514 | 1.28618597 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
